cvs caremark tirzepatide coverage decides to remove Zepbound from CVS Caremark formulary Super Awesome Timing CVS Caremark

Get answers to frequently asked questions about RYBELSUS (semaglutide), a GLP-1 pill for type 2 diabetes

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs dont work the same for everyone

Check it out for helpful tips on managing men

Watch our video

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. | The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.